Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Isner

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Circulation|May 1, 2002
Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemiaDouglas W Losordo, Peter R Vale, Robert C Hendel, et al.
Circulation|January 24, 2002
Targeting kinin B(1) receptor for therapeutic neovascularizationCostanza Emanueli, Maria Bonaria Salis, Tiziana Stacca, et al.
Circulation|April 27, 2005
Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factorYoung-sup Yoon, Shigeki Uchida, Osamu Masuo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGFRudolf Kirchmair, Anne B Tietz, Eleftheria Panagiotou, et al.
Vascular Medicine (London, England)|June 1, 2005
Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemiaMarta Bosch-Marcé, Roberto Pola, Andrea B Wecker, et al.
The Journal of Clinical Investigation|March 6, 2003
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedemaYoung-Sup Yoon, Toshinori Murayama, Edwin Gravereaux, et al.
Journal of Interventional Cardiology|March 25, 2005
Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patientsJohn P Reilly, Mark A Grise, F David Fortuin, et al.
Circulation|January 29, 2003
Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemiaAtsuhiko Kawamoto, Tengis Tkebuchava, Jun-Ichi Yamaguchi, et al.
The American Journal of Cardiology|August 14, 2003
One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patientsF David Fortuin, Peter Vale, Douglas W Losordo, et al.
Circulation|June 24, 2004
Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosisDirk H Walter, Manfred Cejna, Larry Diaz-Sandoval, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Circulation|May 1, 2002
Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemiaDouglas W Losordo, Peter R Vale, Robert C Hendel, et al.
Circulation|January 24, 2002
Targeting kinin B(1) receptor for therapeutic neovascularizationCostanza Emanueli, Maria Bonaria Salis, Tiziana Stacca, et al.
Circulation|April 27, 2005
Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factorYoung-sup Yoon, Shigeki Uchida, Osamu Masuo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGFRudolf Kirchmair, Anne B Tietz, Eleftheria Panagiotou, et al.
Vascular Medicine (London, England)|June 1, 2005
Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemiaMarta Bosch-Marcé, Roberto Pola, Andrea B Wecker, et al.
The Journal of Clinical Investigation|March 6, 2003
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedemaYoung-Sup Yoon, Toshinori Murayama, Edwin Gravereaux, et al.
Journal of Interventional Cardiology|March 25, 2005
Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patientsJohn P Reilly, Mark A Grise, F David Fortuin, et al.
Circulation|January 29, 2003
Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemiaAtsuhiko Kawamoto, Tengis Tkebuchava, Jun-Ichi Yamaguchi, et al.
The American Journal of Cardiology|August 14, 2003
One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patientsF David Fortuin, Peter Vale, Douglas W Losordo, et al.
Circulation|June 24, 2004
Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosisDirk H Walter, Manfred Cejna, Larry Diaz-Sandoval, et al.
Pageof 4